The regulation of health care providers' payments when horizontal and vertical differentiation matter
This paper analyzes the regulation of payment schemes for health care providers competing in both quality and product differentiation of their services. The regulator uses two instruments: a prospective payment per patient and a cost reimbursement rate. When the regulator can only use a prospective...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2012
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22362
- Acceso en línea:
- https://doi.org/10.1016/j.jhealeco.2012.04.002
https://repository.urosario.edu.co/handle/10336/22362
- Palabra clave:
- Differentiation
Health care
Health services
Regulatory framework
Article
Economic aspect
Government regulation
Health care cost
Health care quality
Health insurance
Patient transport
Prospective payment
Reimbursement
Remuneration
Resource allocation
Social welfare
Europe
Government regulation
Health care costs
Health personnel
Humans
Prospective payment system
Quality of health care
Reimbursement mechanisms
Health care
Horizontal and vertical differentiation
Mixed payment schemes
Regulation
economic
Models
- Rights
- License
- Abierto (Texto Completo)
Summary: | This paper analyzes the regulation of payment schemes for health care providers competing in both quality and product differentiation of their services. The regulator uses two instruments: a prospective payment per patient and a cost reimbursement rate. When the regulator can only use a prospective payment, the optimal price involves a trade-off between the level of quality provision and the level of horizontal differentiation. If this pure prospective payment leads to underprovision of quality and overdifferentiation, a mixed reimbursement scheme allows the regulator to improve the allocation efficiency. This is true for a relatively low level of patients' transportation costs. We also show that if the regulator cannot commit to the level of the cost reimbursement rate, the resulting allocation can dominate the one with full commitment. This occurs when the transportation cost is low or high enough, and the full commitment solution either implies full or zero cost reimbursement. © 2012 Elsevier B.V. |
---|